Insights

Innovative Material Technology AMSilk specializes in bioengineered silk proteins utilizing advanced science and technologies like DNA editing, protein engineering, and precision fermentation. Their groundbreaking biogenic materials offer high-performance qualities that can address needs in diverse industries such as textiles, biomedical, automotive, and homecare, presenting opportunities for collaborations in high-tech material applications.

Strategic Industry Collaborations The company's recent partnerships with Ajinomoto and Cargill demonstrate a strong emphasis on bio-manufacturing and fermentation expertise. This positions AMSilk as a key player capable of scaling production and innovating within bio-based material markets, ideal for engaging industrial suppliers or companies seeking advanced sustainable materials.

Robust Financial Growth AMSilk has secured significant funding, including over $60 million in recent strategic financing and a Series C investment of around EUR 25 million. This financial strength enables expansion into new markets and supports R&D efforts, making it an attractive partner for businesses looking to collaborate on innovative material solutions.

Market Expansion Potential With an increasing focus on sustainable and bio-based materials, AMSilk's diverse application areas and recent expansions position them well for growth. Engaging with industries seeking eco-friendly alternatives—such as automotive, textiles, and biomedical sectors—could open up new sales channels and partnership opportunities.

Key Leadership and Talent The appointment of a Chief Scientific Officer reflects AMSilk’s commitment to innovation and scientific excellence. This focus on cutting-edge research and development indicates their readiness to develop customized solutions and establish strategic collaborations with organizations aiming to leverage bioengineered materials for competitive advantage.

Similar companies to AMSilk GmbH | Biotech Materials

AMSilk GmbH | Biotech Materials Tech Stack

AMSilk GmbH | Biotech Materials uses 8 technology products and services including DATEV, Adobe, Adobe InDesign, and more. Explore AMSilk GmbH | Biotech Materials's tech stack below.

  • DATEV
    Accounting And Finance
  • Adobe
    Audio, Video, Graphics
  • Adobe InDesign
    Cad & Graphics
  • SAP
    Customer Relationship Management
  • JSON-LD
    Javascript Frameworks
  • Lodash
    Javascript Libraries
  • PWA
    Miscellaneous
  • Personio
    Recruitment Marketing

Media & News

AMSilk GmbH | Biotech Materials's Email Address Formats

AMSilk GmbH | Biotech Materials uses at least 1 format(s):
AMSilk GmbH | Biotech Materials Email FormatsExamplePercentage
First.Last@amsilk.comJohn.Doe@amsilk.com
49%
First.MiddleLast@amsilk.comJohn.MichaelDoe@amsilk.com
1%
First.Last@amsilk.comJohn.Doe@amsilk.com
49%
First.MiddleLast@amsilk.comJohn.MichaelDoe@amsilk.com
1%

Frequently Asked Questions

Where is AMSilk GmbH | Biotech Materials's headquarters located?

Minus sign iconPlus sign icon
AMSilk GmbH | Biotech Materials's main headquarters is located at Anna-Sigmund Straße 1-3, Neuried, Bavaria 82061, DE. The company has employees across 2 continents, including EuropeNorth America.

What is AMSilk GmbH | Biotech Materials's official website and social media links?

Minus sign iconPlus sign icon
AMSilk GmbH | Biotech Materials's official website is amsilk.com and has social profiles on LinkedInCrunchbase.

What is AMSilk GmbH | Biotech Materials's SIC code NAICS code?

Minus sign iconPlus sign icon
AMSilk GmbH | Biotech Materials's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does AMSilk GmbH | Biotech Materials have currently?

Minus sign iconPlus sign icon
As of October 2025, AMSilk GmbH | Biotech Materials has approximately 79 employees across 2 continents, including EuropeNorth America. Key team members include Ceo: U. S.Chief Scientific Officer: G. V.Chief Financial Officer: R. F.. Explore AMSilk GmbH | Biotech Materials's employee directory with LeadIQ.

What industry does AMSilk GmbH | Biotech Materials belong to?

Minus sign iconPlus sign icon
AMSilk GmbH | Biotech Materials operates in the Biotechnology Research industry.

What technology does AMSilk GmbH | Biotech Materials use?

Minus sign iconPlus sign icon
AMSilk GmbH | Biotech Materials's tech stack includes DATEVAdobeAdobe InDesignSAPJSON-LDLodashPWAPersonio.

What is AMSilk GmbH | Biotech Materials's email format?

Minus sign iconPlus sign icon
AMSilk GmbH | Biotech Materials's email format typically follows the pattern of First.Last@amsilk.com. Find more AMSilk GmbH | Biotech Materials email formats with LeadIQ.

How much funding has AMSilk GmbH | Biotech Materials raised to date?

Minus sign iconPlus sign icon
As of October 2025, AMSilk GmbH | Biotech Materials has raised $35M in funding. The last funding round occurred on Sep 09, 2025 for $35M.

When was AMSilk GmbH | Biotech Materials founded?

Minus sign iconPlus sign icon
AMSilk GmbH | Biotech Materials was founded in 2008.

AMSilk GmbH | Biotech Materials

Biotechnology ResearchGermany51-200 Employees

AMSilk's Biogenius Materials made from silk proteins are setting new standards in material innovation. Using cutting-edge science and the most advanced technologies like DNA edition, protein engineering and precision fermentation, we transform biogenic materials inspired by nature into groundbreaking Biongenius Materials. At AMSilk, we turn man-made proteins into formulations, including fibers and yarns, hydrogels and silk powder. The high-performance qualities of our material enable a wide range of applications in the textile, homecare, biomedical, and automobile industries and bring breakthrough benefits for products and customers.

Section iconCompany Overview

Headquarters
Anna-Sigmund Straße 1-3, Neuried, Bavaria 82061, DE
Website
amsilk.com
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2008
Employees
51-200

Section iconFunding & Financials

  • $35M

    AMSilk GmbH | Biotech Materials has raised a total of $35M of funding over 6 rounds. Their latest funding round was raised on Sep 09, 2025 in the amount of $35M.

  • $1M$10M

    AMSilk GmbH | Biotech Materials's revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $35M

    AMSilk GmbH | Biotech Materials has raised a total of $35M of funding over 6 rounds. Their latest funding round was raised on Sep 09, 2025 in the amount of $35M.

  • $1M$10M

    AMSilk GmbH | Biotech Materials's revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.